Medindia LOGIN REGISTER
Medindia
Advertisement

Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference

Friday, September 18, 2009 General News
Advertisement


EMERYVILLE, Calif., July 29 Bionovo, Inc. (Nasdaq: BNVI), a drug discovery and development company focused on the unmet needs in women's health and oncology, today announced that Dr. Mary Tagliaferri, President and Chief Medical Officer, and Tom Chesterman, Senior Vice President and CFO, will be presenting at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference at 1:45 p.m. EDT on Wednesday, August 5, 2009. The event will be held at the Millennium Broadway Hotel in New York City.
Advertisement

Interested parties can access a live webcast of the presentation by visiting http://www.bmocm.com/conferences/2009healthcare/webcast/. A replay will be available for 6 months following the conference.
Advertisement

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

SOURCE Bionovo, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close